News
CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...
Women who replaced their lunchtime diet beverage with water had greater weight loss and achieved diabetes remission compared ...
Inhaled insulin is an “important alternative” to injected rapid-acting analog insulin for children and teens with diabetes, according to a speaker at the American Diabetes Association Scientific ...
This challenge Kickstarts additional investments through the new ADA Innovation Fund CHICAGO, June 21, 2025 /PRNewswire/ -- As the American Diabetes ...
Diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable treatments such as ...
Developments from two studies highlighting the potential for machine learning leveraging artificial intelligence (AI) technology to improve early-stage identification of type 1 diabetes were presented ...
1d
MedPage Today on MSNNovel Oral GLP-1 Agent Cuts A1c, Weight in Early DiabetesCHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...
The first diabetes and obesity pill that is similar to Ozempic — but in tablet form — may actually outperform the popular ...
Proteomics International has launched its PromarkerD diagnostic test at a major diabetes event, offering early diabetic ...
RA bofanglutide injection demonstrated a favorable safety and tolerability profile after 23 weeks of once weekly ...
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results